Arkolith/Insider Trading/ELYM/Form 4

Morisset Valerie

EVP, R&D AND CSOEliem Therapeutics, Inc. (ELYM) · full profile →Form 4 · filed Jul 16, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$651K
Net Open-Market Flow
-$651K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2024Sell(S)42K$7.01$297K252K
Jul 12, 2024Sell(S)50K$7.07$354K295K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019610) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML